ey0017.8-10 | New Hope | ESPEYB17
N Pode-Shakked
, A Blau
, B Pode-Shakked
, D Tiosano
, N Weintrob
, O Eyal
, A Zung
, F Levy-Khademi
, Y Tenenbaum-Rakover
, D Zangen
, D Gillis
, O Pinhas-Hamiel
, N Loewenthal
, L de Vries
, Z Landau
, M Rachmiel
, A Abu-Libdeh
, A Eliakim
, D Strich
, I Koren
, A German
, J Sack
, S Almashanu
To read the full abstract: J Clin Endocrinol Metab. 2019; 104(8): 31723180. PMID: 30865229.Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency was among the first genetic disorders included in newborn screening (NBS) programs worldwide, based on 17-hydroxyprogesterone (17OHP) concentrations determined in dried blood spots (1). However, the success of NBS for...